Tertiary drug information sources for treatment and prevention of COVID-19

OBJECTIVE: To evaluate tertiary drug information databases in terms of scope, consistency of content, and completeness of COVID-19 drug information. METHODS: Five electronic drug information databases: Clinical Pharmacology, Lexi-Drugs, AHFS DI (American Hospital Formulary Service Drug Information),...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckett, Robert D., Brattain, Yashawna, Truong, Judy, Engle, Genevieve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University Library System, University of Pittsburgh 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621729/
https://www.ncbi.nlm.nih.gov/pubmed/37928123
http://dx.doi.org/10.5195/jmla.2023.1662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621729/
https://www.ncbi.nlm.nih.gov/pubmed/37928123
http://dx.doi.org/10.5195/jmla.2023.1662

Ejemplares similares